PE121299A1 - Isoquinolinas - Google Patents
IsoquinolinasInfo
- Publication number
- PE121299A1 PE121299A1 PE1998000973A PE00097398A PE121299A1 PE 121299 A1 PE121299 A1 PE 121299A1 PE 1998000973 A PE1998000973 A PE 1998000973A PE 00097398 A PE00097398 A PE 00097398A PE 121299 A1 PE121299 A1 PE 121299A1
- Authority
- PE
- Peru
- Prior art keywords
- alkylene
- alkyl
- aryl
- halogen
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 abstract 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 abstract 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 210000002865 immune cell Anatomy 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960005356 urokinase Drugs 0.000 abstract 1
- 210000004291 uterus Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UN COMPUESTO I, DONDE UNO DE R1 Y R2 ES H Y EL OTRO ES N=C(NH2)2 O NHC(=NH)NH2; R3 ES H, HALOGENO, ALQUILO C1-C6, ALCOXI CI-C6 OPCIONALMENTE SUSTITUIDO POR HALOGENO; R4, R5, R6 Y R7 SON H, OH, HALOGENO, ALQUILO C1-C6, ALCOXI C1-C6, (Cm-ALQUILENO)CO2R8, (Cm-ALQUILENO)CONR9R10, (Cm-ALQUILENO)NR9SO2R11, X-ARILO O X-HET O CUANDO DOS DE R4 Y R5 O R5 Y R6 O R6 Y R7 FORMAN -O-(Cn-ALQUILENO)-O-; R8 ES H, ALQUILO C1-C6, ARILO(ALQUILENO C1-C6); R9 Y R10 SON H, ALQUILO C1-C6, ARIL(ALQUILENO C1-C6, ARILO, HETEROARILO, ENTRE OTROS O JUNTOS FORMAN ALQUILENO, UN ANILLO DE 4-7 MIEMBROS; R11 ES ARILO, HETEROARILO, ALQUILO C1-C6; R12 ES H, ALQUILO C1-C6, CO(ALQUILO C1-C6); X ES UN ENLACE, Cn-ALQUILENO, O, (Cn-ALQUILENO)O, ENTRE OTROS; m ES 0-3; n ES 1-3. UN COMPUESTO PREFERIDO ES (4-CLORO-7-(2-METOXIFENIL)ISOQUINOLIN-1-IL)GUANIDINA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN INHIBIDOR DE UROQUINASA (uPA) Y PUEDE SER UTIL PARA EL TRATAMIENTO DE ULCERA DERMICA CRONICA, ANGIOGENESIS, REESTRUCTURACION OSEA, IMPLANTACION DEL EMBRION EN EL UTERO, INFILTRACION DE CELULAS INMUNES EN SITIOS INFLAMATORIOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721964.6A GB9721964D0 (en) | 1997-10-16 | 1997-10-16 | Isoquinolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE121299A1 true PE121299A1 (es) | 1999-12-01 |
Family
ID=10820680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000973A PE121299A1 (es) | 1997-10-16 | 1998-10-15 | Isoquinolinas |
Country Status (41)
| Country | Link |
|---|---|
| US (1) | US6248738B1 (es) |
| EP (1) | EP1023268B1 (es) |
| JP (1) | JP3600794B2 (es) |
| KR (1) | KR20010031163A (es) |
| CN (1) | CN1275979A (es) |
| AP (1) | AP959A (es) |
| AR (1) | AR015964A1 (es) |
| AT (1) | ATE240943T1 (es) |
| AU (1) | AU727315B2 (es) |
| BG (1) | BG104328A (es) |
| BR (1) | BR9812922A (es) |
| CA (1) | CA2306782C (es) |
| CO (1) | CO4990959A1 (es) |
| DE (1) | DE69814894T2 (es) |
| DK (1) | DK1023268T3 (es) |
| DZ (1) | DZ2624A1 (es) |
| EA (1) | EA002632B1 (es) |
| ES (1) | ES2197514T3 (es) |
| GB (1) | GB9721964D0 (es) |
| GT (1) | GT199800159A (es) |
| HN (1) | HN1998000158A (es) |
| HR (1) | HRP20000217A2 (es) |
| HU (1) | HUP0004491A3 (es) |
| ID (1) | ID23913A (es) |
| IL (1) | IL135122A0 (es) |
| IS (1) | IS5412A (es) |
| MA (1) | MA26552A1 (es) |
| NO (1) | NO20001924L (es) |
| NZ (1) | NZ503390A (es) |
| OA (1) | OA11348A (es) |
| PA (1) | PA8461601A1 (es) |
| PE (1) | PE121299A1 (es) |
| PL (1) | PL340035A1 (es) |
| PT (1) | PT1023268E (es) |
| SK (1) | SK4872000A3 (es) |
| TN (1) | TNSN98185A1 (es) |
| TR (1) | TR200001010T2 (es) |
| UY (2) | UY25211A1 (es) |
| WO (1) | WO1999020608A1 (es) |
| YU (1) | YU21100A (es) |
| ZA (1) | ZA989412B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000005214A2 (en) * | 1998-07-24 | 2000-02-03 | Pfizer Inc. | Isoquinolines as urokinase inhibitors |
| DE19940389A1 (de) | 1999-08-25 | 2001-03-01 | Wilex Biotechnology Gmbh | Selektive Inhibitoren des Urokinase-Plasminogen Aktivators |
| ES2172376B1 (es) * | 2000-01-28 | 2003-11-16 | Servier Lab | Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
| DE10013715A1 (de) | 2000-03-20 | 2001-09-27 | Wilex Biotechnology Gmbh | Hochselektive Inhibitoren des Urokinase-Plasminogenaktivators |
| GB0026490D0 (en) * | 2000-10-30 | 2000-12-13 | Pfizer Ltd | Process |
| JP2005500284A (ja) * | 2001-06-11 | 2005-01-06 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｐ３８のイソキノリンインヒビター |
| US7109354B2 (en) | 2002-05-28 | 2006-09-19 | 3-Dimensional Pharmaceuticals, Inc. | Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| US7176220B2 (en) * | 2002-11-20 | 2007-02-13 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as pharmaceutical agent |
| GB0326964D0 (en) * | 2003-11-19 | 2003-12-24 | Glaxo Group Ltd | Chemical compounds |
| WO2005113509A1 (en) * | 2004-05-20 | 2005-12-01 | Japan Tobacco Inc. | Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| MY134672A (en) * | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
| WO2006090783A1 (ja) * | 2005-02-25 | 2006-08-31 | Kowa Co., Ltd. | ４－フルオロイソキノリン－５－スルホニルハライド又はその塩の製造方法 |
| RU2410087C2 (ru) | 2005-06-24 | 2011-01-27 | Вилекс Аг | Применение ингибиторов урокиназы для лечения и/или предупреждения невропатологических заболеваний |
| KR101023635B1 (ko) * | 2006-03-06 | 2011-03-22 | 니뽄 다바코 산교 가부시키가이샤 | 4-옥소퀴놀린 화합물 제조 방법 |
| TWI795381B (zh) | 2016-12-21 | 2023-03-11 | 比利時商健生藥品公司 | 作為ｍａｌｔ１抑制劑之吡唑衍生物 |
| CN106831575B (zh) * | 2017-02-13 | 2019-04-16 | 北京六合宁远科技有限公司 | 一种1-氨基异喹啉-6-甲醇的制备方法 |
| CN113877483B (zh) * | 2021-07-20 | 2023-11-24 | 烟台宁远药业有限公司 | 医药中间体卤代异喹啉类硼酸的低温连续合成装置与方法 |
| CN115286573B (zh) * | 2022-08-04 | 2024-12-10 | 常州工程职业技术学院 | 一种1-烷氧基异喹啉化合物的绿色合成方法 |
-
1997
- 1997-10-16 GB GBGB9721964.6A patent/GB9721964D0/en not_active Ceased
-
1998
- 1998-10-05 EA EA200000320A patent/EA002632B1/ru not_active IP Right Cessation
- 1998-10-05 KR KR1020007004083A patent/KR20010031163A/ko not_active Abandoned
- 1998-10-05 NZ NZ503390A patent/NZ503390A/en unknown
- 1998-10-05 US US09/424,497 patent/US6248738B1/en not_active Expired - Fee Related
- 1998-10-05 ES ES98954357T patent/ES2197514T3/es not_active Expired - Lifetime
- 1998-10-05 DE DE69814894T patent/DE69814894T2/de not_active Expired - Fee Related
- 1998-10-05 WO PCT/EP1998/006353 patent/WO1999020608A1/en not_active Ceased
- 1998-10-05 PT PT98954357T patent/PT1023268E/pt unknown
- 1998-10-05 AU AU11508/99A patent/AU727315B2/en not_active Ceased
- 1998-10-05 TR TR2000/01010T patent/TR200001010T2/xx unknown
- 1998-10-05 PL PL98340035A patent/PL340035A1/xx unknown
- 1998-10-05 CA CA002306782A patent/CA2306782C/en not_active Expired - Fee Related
- 1998-10-05 BR BR9812922-8A patent/BR9812922A/pt not_active Application Discontinuation
- 1998-10-05 HU HU0004491A patent/HUP0004491A3/hu unknown
- 1998-10-05 CN CN98810108A patent/CN1275979A/zh active Pending
- 1998-10-05 ID IDW20000691A patent/ID23913A/id unknown
- 1998-10-05 YU YU21100A patent/YU21100A/sh unknown
- 1998-10-05 EP EP98954357A patent/EP1023268B1/en not_active Expired - Lifetime
- 1998-10-05 DK DK98954357T patent/DK1023268T3/da active
- 1998-10-05 SK SK487-2000A patent/SK4872000A3/sk unknown
- 1998-10-05 AT AT98954357T patent/ATE240943T1/de not_active IP Right Cessation
- 1998-10-05 HR HR20000217A patent/HRP20000217A2/hr not_active Application Discontinuation
- 1998-10-05 JP JP2000516950A patent/JP3600794B2/ja not_active Expired - Fee Related
- 1998-10-05 IL IL13512298A patent/IL135122A0/xx unknown
- 1998-10-08 HN HN1998000158A patent/HN1998000158A/es unknown
- 1998-10-09 GT GT199800159A patent/GT199800159A/es unknown
- 1998-10-12 PA PA19988461601A patent/PA8461601A1/es unknown
- 1998-10-14 AR ARP980105113A patent/AR015964A1/es not_active Application Discontinuation
- 1998-10-14 DZ DZ980234A patent/DZ2624A1/xx active
- 1998-10-14 MA MA25298A patent/MA26552A1/fr unknown
- 1998-10-14 TN TNTNSN98185A patent/TNSN98185A1/fr unknown
- 1998-10-15 ZA ZA9809412A patent/ZA989412B/xx unknown
- 1998-10-15 PE PE1998000973A patent/PE121299A1/es not_active Application Discontinuation
- 1998-10-15 UY UY25211A patent/UY25211A1/es unknown
- 1998-10-16 CO CO98060365A patent/CO4990959A1/es unknown
- 1998-10-19 AP APAP/P/1998/001366A patent/AP959A/en active
- 1998-12-08 UY UY25291A patent/UY25291A1/es not_active IP Right Cessation
-
2000
- 2000-03-21 IS IS5412A patent/IS5412A/is unknown
- 2000-04-07 OA OA1200000102A patent/OA11348A/en unknown
- 2000-04-11 BG BG104328A patent/BG104328A/bg unknown
- 2000-04-13 NO NO20001924A patent/NO20001924L/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE121299A1 (es) | Isoquinolinas | |
| PE106499A1 (es) | Antagonistas del receptor ccr-3 | |
| PE20010150A1 (es) | Derivados de piperazina utiles como antagonistas ccr5 | |
| MX170768B (es) | Nuevo uso industrial de carbamatos de poli(oxia lquileno) como agentes de control de deposito | |
| PE109198A1 (es) | Compuestos 1,4-heterociclicos inhibidores de metaloproteasas | |
| PE107898A1 (es) | Compuestos 1,3-diheterociclicos, inhibidores de metaloproteasa | |
| ES2093672T3 (es) | Composicion blanqueante liquida acuosa. | |
| ES2102648T3 (es) | Composiciones antiestaticas de polimero sulfonado/oxido de vanadio. | |
| ATE132134T1 (de) | Benzamide | |
| ES2084347T3 (es) | Derivados de 5-heteroil-indol. | |
| FI873113A0 (fi) | Tvaettmedelskomposition. | |
| GR3022571T3 (en) | Use of sulfonamides as drug and new sulfonamides | |
| DE60004066D1 (de) | Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten | |
| NO994803D0 (no) | Bionedbrytbare polymerer som er kjedeforlenget med fosfater, blandinger, gjenstander og fremgangsmÕte for fremstilling og anvendelse derav | |
| ATE85351T1 (de) | Kondensate von cyclischen harnstoffen, zubereitungen zur behandlung von textilien und papier sowie cyclische harnstoffe. | |
| PE20040634A1 (es) | Prodrogas 2' y 3' de nucleosidos modificados | |
| PE20040581A1 (es) | Inhibidores heterociclicos de cinasas | |
| ES2123065T3 (es) | Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas. | |
| IS2054B (is) | Ný súlfalyf og hliðstæðuferli til framleiðslu þeirra | |
| ES8505251A3 (es) | Procedimiento para la obtencion del clorhidrato de 8-4-4-(2-pirimidinil)-1-piperazinil-butil-8-azaspiro 4,5-decano-7,9- diona. | |
| AR037926A1 (es) | Polimeros para composiciones de limpieza para el lavado de ropa | |
| FI903826A0 (fi) | Ny arginindeiminase, dess framstaellningsfoerfarande och ett anti-cancermedel innehaollande denna enzym som effectiv ingredient. | |
| TR199902848T2 (xx) | Ergolin t�revleri ve bunlar�n somatostatin resept�r antagonist olarak kullan�mlar� | |
| DE60313880D1 (de) | Flüssige waschmittelzusammensetzungen mit silikonadditiven | |
| ATE80645T1 (de) | ''diurethane als stabilisierende zusaetze in dichtungsmassen''. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |